Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Oren

Showing results (151-160 of 172) with videos related to

Pageof 18
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2021
<i>TP53</i> missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironmentMartino Maddalena, Giuseppe Mallel, Nishanth Belugali Nataraj, et al.
Nucleic Acids Research|October 17, 2017
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormoneYehoshua Enuka, Morris E Feldman, Animesh Chowdhury, et al.
Genes & Development|October 4, 2008
The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expressionEfrat Shema, Itay Tirosh, Yael Aylon, et al.
Cancer Cell|July 30, 2013
A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanismAriel Pribluda, Ela Elyada, Zoltan Wiener, et al.
Nature Communications|May 19, 2022
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patientsOri Hassin, Nishanth Belugali Nataraj, Michal Shreberk-Shaked, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2022
Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteinsSaptaparna Mukherjee, Martino Maddalena, YiQing Lü, et al.
Scientific Reports|July 2, 2016
Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discoveryKristin Stock, Marta F Estrada, Suzana Vidic, et al.
Cell Reports|May 26, 2021
PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFRSoma Ghosh, Nishanth Belugali Nataraj, Ashish Noronha, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2023
p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cellsOri Hassin, Miriam Sernik, Adi Seligman, et al.
Molecular Cell|March 3, 2011
Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaksLilach Moyal, Yaniv Lerenthal, Mali Gana-Weisz, et al.
Pageof 18

Showing results (151-160 of 172) with videos related to

Sort By:
Pageof 18
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2021
<i>TP53</i> missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironmentMartino Maddalena, Giuseppe Mallel, Nishanth Belugali Nataraj, et al.
Nucleic Acids Research|October 17, 2017
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormoneYehoshua Enuka, Morris E Feldman, Animesh Chowdhury, et al.
Genes & Development|October 4, 2008
The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expressionEfrat Shema, Itay Tirosh, Yael Aylon, et al.
Cancer Cell|July 30, 2013
A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanismAriel Pribluda, Ela Elyada, Zoltan Wiener, et al.
Nature Communications|May 19, 2022
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patientsOri Hassin, Nishanth Belugali Nataraj, Michal Shreberk-Shaked, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2022
Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteinsSaptaparna Mukherjee, Martino Maddalena, YiQing Lü, et al.
Scientific Reports|July 2, 2016
Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discoveryKristin Stock, Marta F Estrada, Suzana Vidic, et al.
Cell Reports|May 26, 2021
PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFRSoma Ghosh, Nishanth Belugali Nataraj, Ashish Noronha, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2023
p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cellsOri Hassin, Miriam Sernik, Adi Seligman, et al.
Molecular Cell|March 3, 2011
Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaksLilach Moyal, Yaniv Lerenthal, Mali Gana-Weisz, et al.
Pageof 18